⌘K

Login Start Free

Home/Filings/4/0001104659-20-137412

4//SEC Filing

Xu Weihao 4

Accession 0001104659-20-137412

CIK 0000895051other

View on SEC.gov Company Profile

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:05 PM ET

Size

10.4 KB

Accession

0001104659-20-137412

Insider Transaction Report

Form 4

Period: 2020-12-16

CASI Pharmaceuticals, Inc.CASI

Chief Financial Officer

Transactions

Purchase
Common Stock
2020-12-16$2.44/sh+2,000$4,880→ 6,000 total(indirect: By Spouse)
Purchase
Common Stock
2020-12-17$2.63/sh+2,279$5,994→ 10,000 total(indirect: By Spouse)
Purchase
Common Stock
2020-12-17$2.64/sh+1,721$4,543→ 7,721 total(indirect: By Spouse)
Award
Employee Stock Option (Right to Buy)
2020-12-16+800,000→ 800,000 total
Exercise: $2.61Exp: 2030-12-16→ Common Stock (800,000 underlying)

Footnotes (1)

[F1]The stock options vest as follows: 160,000 options on each of the first and second anniversaries of the date of grant and 240,000 options on each of the third and fourth anniversaries of the date of grant.

Documents

1 file

4
tm2038581d2_form4.xmlPrimary
FORM 4

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1

filerCIK 0001835368

Filing Metadata

Form type: 4
Filed: Dec 17, 7:00 PM ET
Accepted: Dec 18, 4:05 PM ET
Size: 10.4 KB

View on SEC.gov